Pharmaceutical compositions and solid forms

Details for Australian Patent Application No. 2010270361 (hide)

Owner Novartis AG

Inventors Berghausen, Joerg; Haug, Claire; Herbig, Michael; Hu, Bin; Jonat, Stephane; Leleti, Rajender; Meingassner, Josef Gottfried; Monnier, Stephanie; Napp, Matthias; Prashad, Mahavir; Stuetz, Anton; Thakur, Ranjit

Agent Davies Collison Cave

Pub. Number AU-A-2010270361

PCT Pub. Number WO2011/003858

Priority 61/223,269 06.07.09 US

Filing date 5 July 2010

Wipo publication date 13 January 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/505 (2006.01) - Pyrimidines

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61P 17/00 (2006.01) Drugs for dermatological disorders

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2011/003858 Priority application(s): WO2011/003858

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010270363-Process for the manufacture of alkenones

2010270359-Process for the manufacture of halogenated precursors of alkenones under specific conditions